[EN] HETEROCYCLIC PAD4 INHIBITORS [FR] INHIBITEURS DE PAD4 HÉTÉROCYCLIQUES
摘要:
The disclosure generally relates to 3,5,6,7-tetrahydro-8H-imidazo[4,5-b][1,6]naphthyridin-8-one compounds of Formula I, which are inhibitors of PAD4, methods for preparing these compounds, pharmaceutical compositions comprising these compounds and uses of these compounds in the treatment of a disease or a disorder associated with PAD4 enzyme activity.
[EN] HETEROCYCLIC PAD4 INHIBITORS [FR] INHIBITEURS DE PAD4 HÉTÉROCYCLIQUES
摘要:
The disclosure generally relates to 3,5,6,7-tetrahydro-8H-imidazo[4,5-b][1,6]naphthyridin-8-one compounds of Formula I, which are inhibitors of PAD4, methods for preparing these compounds, pharmaceutical compositions comprising these compounds and uses of these compounds in the treatment of a disease or a disorder associated with PAD4 enzyme activity.